Mersana Therapeutics, Inc. (MRSN)
NASDAQ: MRSN · Real-Time Price · USD
7.08
-0.07 (-0.98%)
Sep 18, 2025, 9:24 AM EDT - Market open
Mersana Therapeutics Market Cap
Mersana Therapeutics has a market cap or net worth of $35.33 million as of September 18, 2025. Its market cap has decreased by -81.77% in one year.
Market Cap
35.33M
Enterprise Value
-20.67M
1-Year Change
-81.77%
Ranking
Category
Stock Price
$7.08
Market Cap Chart
Since June 28, 2017, Mersana Therapeutics's market cap has decreased from $317.00M to $35.33M, a decrease of -88.85%. That is a compound annual growth rate of -23.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2025 | 35.70M | -79.80% |
| Dec 31, 2024 | 176.70M | -36.85% |
| Dec 29, 2023 | 279.80M | -52.15% |
| Dec 30, 2022 | 584.70M | 30.72% |
| Dec 31, 2021 | 447.30M | -75.46% |
| Dec 31, 2020 | 1.82B | 564.25% |
| Dec 31, 2019 | 274.40M | 190.06% |
| Dec 31, 2018 | 94.60M | -74.69% |
| Dec 29, 2017 | 373.80M | 17.92% |
| Jun 28, 2017 | 317.00M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 682.40B |
| Johnson & Johnson | 426.76B |
| AbbVie | 390.07B |
| UnitedHealth Group | 309.39B |
| Novo Nordisk | 260.64B |
| AstraZeneca | 241.43B |
| Novartis AG | 237.64B |
| Abbott Laboratories | 233.52B |